Tower Research Capital LLC (TRC) - PROTAGONIST THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$128,803
+49.6%
7,722
+147.7%
0.00%
+33.3%
Q2 2023$86,119
+226528.9%
3,118
+88.1%
0.00%
+200.0%
Q1 2023$38
+100.0%
1,658
-5.1%
0.00%0.0%
Q4 2022$19
-100.0%
1,747
-93.6%
0.00%
-75.0%
Q3 2022$229,000
-42.9%
27,154
-46.5%
0.00%
-55.6%
Q2 2022$401,000
+174.7%
50,723
+720.4%
0.01%
+800.0%
Q1 2022$146,000
-51.7%
6,183
-30.0%
0.00%
-80.0%
Q4 2021$302,000
+40.5%
8,835
-27.2%
0.01%0.0%
Q3 2021$215,000
+133.7%
12,133
+493.0%
0.01%
+150.0%
Q2 2021$92,000
+130.0%
2,046
+32.3%
0.00%
+100.0%
Q1 2021$40,000
-82.2%
1,547
-86.2%
0.00%
-85.7%
Q4 2020$225,000
+765.4%
11,171
+735.5%
0.01%
Q3 2020$26,000
-49.0%
1,337
-53.7%
0.00%
-100.0%
Q2 2020$51,000
+155.0%
2,888
-0.4%
0.00%0.0%
Q4 2019$20,000
+1900.0%
2,899
+3765.3%
0.00%
Q2 2019$1,000
-97.9%
75
-98.9%
0.00%
-100.0%
Q4 2018$48,000
+4700.0%
7,128
+5790.9%
0.00%
Q3 2018$1,000
-85.7%
121
-88.4%
0.00%
Q2 2018$7,000
-36.4%
1,047
-19.1%
0.00%
-100.0%
Q1 2018$11,000
-64.5%
1,294
-26.1%
0.00%
-66.7%
Q3 2017$31,0001,7500.00%
Q2 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2017$9,0006560.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders